View Older Stories
-
Kenvue (KVUE) Announces Closing of IPO
-
Kenvue Announces Closing of Initial Public Offering
-
Kenvue (KVUE) Prices Upsized 172.18M Share IPO at $22/sh
-
Johnson & Johnson and Kenvue Announce Pricing of Upsized Kenvue Inc. Initial Public Offering
-
Johnson & Johnson prices consumer spinoff Kenvue at $20-$23 a share in IPO
-
Johnson & Johnson Announces Launch of Kenvue Inc. IPO Roadshow
-
Dow Jones, Nasdaq, S&P 500 weekly preview: Tech takes the earnings stage
-
Buffett's Berkshire Adds Some Apple, Louisiana-Pacific, Paramount Global - 13F
-
3 Rumors Pushing Around Stocks Today
-
Buffett's Berkshire Enters Jefferies, Louisiana-Pacific, Taiwan Semiconductor - 13F
-
Today's Most Important Downgrades
-
Today’s Important Price Target Changes
-
Today’s Important Price Target Changes
-
Buffett's Berkshire Hathaway Enters 8 New Stocks, Including Citi and Paramount Global; Adds to Apple and Chevron
-
Johnson & Johnson (JNJ) PT Raised to $210 at Citi
-
Johnson & Johnson to Participate in Citi's 2022 Virtual Healthcare Conference
-
Reactions to J&J's plans to split into two companies
-
Pre-Open Stock Movers 10/13: (INMD) (ETH) (FL) Higher; (LOOP) (VYGR) (BYND) Lower (more...)
-
Genmab shares drop on legal battle with J&J over cancer drug
-
Pre-Open Stock Movers 08/19: (MNTA) (HUD) (IMVT) Higher; (BMRN) (GLPG) (VIPS) Lower (more...)
-
S&P 500 buybacks reverse declines in Q3 2019; expenditures remain lower than the 2018 levels
-
Wall Street gains as earnings season begins in earnest
-
Stocks pause on unsettled trade deal; earnings eyed
-
S&P 500 Q2 Stock Buybacks Fall 20.1% Sequentially, 13.7% YoY
-
S&P 500 buybacks decline significantly in Q2 2019; expenditures still remain higher than the pre-2018 levels
-
Pre-Open 08/27: (CAL) (JILL) (MO) Higher (SJM) (PM) (RRGB) Lower (more...)
-
Wall Street slips as bank earnings, Trump trade comments weigh
-
Wall St. notches all-time highs on lingering rate-cut optimism
-
PlacementTracker Publishes Q1 2019 PIPE and Private Placement Markets League Tables
-
S&P 500 Q4 2018 Buybacks Set 4th Consecutive Quarterly Record at $223 Billion; 2018 Sets Record $806 Billion
-
Johnson & Johnson (JNJ) PT Raised to $147 at Citi
-
Johnson & Johnson (JNJ) PT Lowered to $139 at Citi
-
Citi Notes Johnson & Johnson (JNJ) completely refutes premise of Reuters article
-
Johnson & Johnson to Participate in the Citi's 2018 Global Healthcare Conference
-
Johnson & Johnson (JNJ) PT Raised to $148 at Citi
-
Pre-Open Movers 10/04: (BKS) (CLDR) (HDP) Higher; (RTEC) (WLDN) (SNAP) Lower (more...)
-
Johnson & Johnson (JNJ) PT Raised to $137 at Citi
-
Johnson & Johnson (JNJ) PT Lowered to $134 at Citi
-
General Surgery Survey 'Very Positive' for Intuitive Surgical (ISRG), Much Less for Medtronic (MDT) and J&J (JNJ) - Citi
-
Johnson & Johnson (JNJ) PT Lowered to $146 at Citi
-
Exclusive: J&J out of race for Pfizer's $20 billion consumer unit as deadline looms
-
Johnson & Johnson to Participate in the Citi 2017 Global Healthcare Conference
-
Johnson & Johnson (JNJ) PT Raised to $149 at Citi
-
Wall Street ticks higher to record close; eyes on earnings, Fed
-
General Surgery Survey 'Very Positive' for Intuitive Surgical (ISRG) - Citi
-
UPDATE: Citi Starts Johnson & Johnson (JNJ) at Neutral
-
Q2 2017 S&P 500 Buybacks Fall 9.8% from Q1, to $120.1 Billion
-
S&P 500 Buybacks Fall 17.5% Year-over-Year to $133.1 Billion for Q1 2017
-
Exclusive: Cancer drugmaker Tesaro attracts takeover interest - sources
-
Pre-Open Stock Movers 01/24: (MPSX) (IIVI) (AKS) Higher; (FSM) (OCUL) (VZ) Lower (more...)